Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
2 clinical trials · Condition
◉ Watch Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
| Record | Firm | Date |
|---|---|---|
| Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma (NCT07691450) | City of Hope Medical Center | 2027-01-03 |
| Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma (NCT02520791) | National Cancer Institute (NCI) | 2016-09-13 |
Track Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type automatically
Every clearance here is in the API, with alerts when new ones post.